Use of letermovir in umbilical cord blood transplantation based on risk scores (2023)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1182/bloodadvances.2023010573
- Subjects: TRANSPLANTES; CÉLULAS-TRONCO; ANTINEOPLÁSICOS; FATORES DE RISCO
- Language: Inglês
- Imprenta:
- Source:
- Título: Blood advances
- ISSN: 2473-9529
- Volume/Número/Paginação/Ano: v. 7, n. 16, p. 4315-4318, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FRANCO, Monica Magdalena Rivera et al. Use of letermovir in umbilical cord blood transplantation based on risk scores. Blood advances, v. 7, n. 16, p. 4315-4318, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55963. Acesso em: 13 fev. 2026. -
APA
Franco, M. M. R., Rafii, H., Volt, F., Kenzey, C., Cappelli, B., Scigliuolo, G. M., et al. (2023). Use of letermovir in umbilical cord blood transplantation based on risk scores. Blood advances, 7( 16), 4315-4318. doi:10.1182/bloodadvances.2023010573 -
NLM
Franco MMR, Rafii H, Volt F, Kenzey C, Cappelli B, Scigliuolo GM, Rocha VG, Raus N, Dalle J-H, Chevallier P. Use of letermovir in umbilical cord blood transplantation based on risk scores [Internet]. Blood advances. 2023 ; 7( 16): 4315-4318.[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55963 -
Vancouver
Franco MMR, Rafii H, Volt F, Kenzey C, Cappelli B, Scigliuolo GM, Rocha VG, Raus N, Dalle J-H, Chevallier P. Use of letermovir in umbilical cord blood transplantation based on risk scores [Internet]. Blood advances. 2023 ; 7( 16): 4315-4318.[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55963 - Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
- Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
- Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
- A novel mutation in RHAG causing Rh-null phenotype in Colombia. [Editorial]
- Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia
- Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
- Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
- Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era
- Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
- Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta]
Informações sobre o DOI: 10.1182/bloodadvances.2023010573 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
